Shares of Kellanova (Symbol: K) have recently surpassed the average 12-month analyst target of $81.07, trading at $81.10 each. When a stock hits the target set by analysts, typically they may either downgrade their recommendation or raise their expectations. How analysts respond often hinges on the company’s recent performance. If Kellanova’s outlook seems positive, it could be time for analysts to increase their price targets.
Within the Zacks coverage universe, there are 15 analysts contributing to Kellanova’s average target. However, this average does not tell the full story. While some analysts project a lower target, one is predicting a price as high as $83.50, while another estimates only $60.00. The variability is reflected in a standard deviation of $6.258.
Analyzing the average price target pulls from the collective insights of numerous analysts rather than relying on just one expert’s opinion. Thus, with shares of Kellanova moving above the average target price, investors have a crucial opportunity to evaluate the company’s position: is $81.07 just a stepping stone towards a higher valuation, or have the shares become overpriced, signaling a good time to sell? Below is a summary of the latest analyst opinions on Kellanova:
Recent K Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong buy ratings: | 0 | 1 | 2 | 3 |
Buy ratings: | 0 | 0 | 0 | 1 |
Hold ratings: | 16 | 15 | 14 | 12 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 3.0 | 2.88 | 2.75 | 2.56 |
The average rating is scored from 1 to 5, with 1 being Strong Buy and 5 indicating Strong Sell. This information is based on data from Zacks Investment Research via Quandl.com. For the latest insights, consider accessing the comprehensive Zacks research report on K—available for free.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• RNDV Options Chain
• NURO market cap history
• Funds Holding WBIB
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.